Internal Medicine, Hematology & Oncology · Cary, NC
NPI
1245305598
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
300 Ashville Ave, Suite 310
Cary, NC, 27518
Phone (919) 233-8585
Groups this clinician bills Medicare through
Medicare paid, 2024
$80K
1,236 services
Medicare patients, 2024
283
Average age 74
Drug cost, 2024
$11.8M
1,405 prescriptions
Company payments, 2025
$208
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Suzanne L Kirby was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 335 times for 168 patients. In total Suzanne L Kirby billed 1,236 services in 16 codes, and Medicare paid $80K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-01-07.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 335 | 168 | $11.91 | $3,990 |
| 99215 Office E&M - Established | Facility | 318 | 161 | $100.07 | $32K |
| 99233 Hospital E&M - Subsequent | Facility | 272 | 58 | $86.63 | $24K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 102 | 57 | $12.32 | $1,256 |
| 99215 Office E&M - Established | Office | 96 | 54 | $102.16 | $9,807 |
| 99223 Hospital E&M - Initial | Facility | 27 | 27 | $123.95 | $3,347 |
| 99214 Office E&M - Established | Facility | 17 | 15 | $42.53 | $723 |
| 99205 Office E&M - New | Facility | 13 | 13 | $117.67 | $1,530 |
| 99205 Office E&M - New | Office | 11 | 11 | $134.41 | $1,478 |
By year: 2022 $51K for 608 services; 2023 $49K for 559 services; 2024 $80K for 1,236 services.
Medicare prescription drug claims, 2024
In 2024, the drug Suzanne L Kirby prescribed most often to Medicare patients was Brukinsa (Zanubrutinib), with 171 prescriptions and refills. In total Suzanne L Kirby wrote 1,405 Medicare prescriptions that cost $11.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Brukinsa Zanubrutinib | 171 | 171 | 17 | $2.3M |
| Lenalidomide Generic | 132 | 132 | 35 | $1.9M |
| Revlimid Lenalidomide | 125 | 125 | 24 | $2.0M |
| Acyclovir Generic | 105 | 135 | 36 | $1,327 |
| Jakafi Ruxolitinib Phosphate | 83 | 83 | Under 11 | $1.4M |
| Ninlaro Ixazomib Citrate | 63 | 63 | Under 11 | $851K |
| Pomalyst Pomalidomide | 42 | 42 | 11 | $966K |
| Imatinib Mesylate Generic | 39 | 39 | Under 11 | $57K |
| Pantoprazole Sodium Generic | 37 | 81 | 18 | $170 |
| Gabapentin Generic | 34 | 34 | 12 | $264 |
| Venclexta Venetoclax | 28 | 28 | Under 11 | $241K |
| Tasigna Nilotinib Hcl | 23 | 23 | Under 11 | $450K |
| Ondansetron Hcl Generic | 23 | 23 | 16 | $116 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 22 | 23 | Under 11 | $89.51 |
| Imbruvica Ibrutinib | 21 | 21 | Under 11 | $325K |
Brand drugs: 675 claims; generic drugs: 730 claims; opioid claims: 27.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Suzanne L Kirby $208 ($208 in general payments such as food, travel and fees) from 3 companies. The largest payer was Servier Pharmaceuticals LLC with $146.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.